Company / Profit Margin
Barinthus Biotherapeutics plc. Profit Margin History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-9145.5%
FY2024
5-year range
-18979.5% / 11.9%
FY2021-FY2024
Trend
-76631.5%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin changed -76631% YoY in FY2024, a notable deviation from the 3-year average annual change of -27200%.
Based on SEC 10-K filings.
-9145.5% in FY2024 with a 3-year CAGR of -8778.2%.
Improved from -18979.5% to -9145.5% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -8778.2pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, profit margin decreased 76631.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -9145.5% | -76631.5% |
| FY2023 | 11.9% | +100.1% |
| FY2022 | -18979.5% | -5067.7% |
| FY2021 | -367.3% | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026